Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.

Summary

It would require telemedicine providers to be properly licensed in New Jersey, to disclose their credentials, and to follow the same standard of care as in‑person visits when prescribing Schedule II ADHD medications to adults. The measure also sets rules for using real‑time or asynchronous technology, informing patients about provider type, maintaining records, and making referrals. The changes aim to ensure safety and accountability while preserving remote care options.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share